Cargando…

Dispensation of attention deficit hyperactivity disorder (ADHD) medications in patients receiving opioid agonist therapy; a national prospective cohort study in Norway from 2015 to 2017

BACKGROUND: It is estimated that up to a third of patients on opioid agonist therapy (OAT) have attention deficit hyperactivity disorder (ADHD). Treatment by ADHD medication, including a centrally acting stimulant (CAS) or atomoxetine is one of the essential approaches. This study evaluates the use...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vold, Jørn Henrik, Aas, Christer, Skurtveit, Svetlana, Odsbu, Ingvild, Chalabianloo, Fatemeh, Halmøy, Anne, Johansson, Kjell Arne, Fadnes, Lars Thore
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068965/ https://www.ncbi.nlm.nih.gov/pubmed/32164615 http://dx.doi.org/10.1186/s12888-020-02526-y

Ejemplares similares

Potentially addictive drugs dispensing to patients receiving opioid agonist therapy: a register-based prospective cohort study in Norway and Sweden from 2015 to 2017
por: Vold, Jørn Henrik, et al.
Publicado: (2020)

Dispensations of benzodiazepines, z-hypnotics, and gabapentinoids to patients receiving opioid agonist therapy; a prospective cohort study in Norway from 2013 to 2017
por: Vold, Jørn Henrik, et al.
Publicado: (2020)

Uptake and predictors of direct-acting antiviral treatment for hepatitis C among people receiving opioid agonist therapy in Sweden and Norway: a drug utilization study from 2014 to 2017
por: Aas, Christer F., et al.
Publicado: (2020)

Too much or too little opioids to patients receiving opioid agonist therapy in Norway (2013–2017): a prospective cohort study
por: Vold, Jørn Henrik, et al.
Publicado: (2020)

On the path towards universal coverage of hepatitis C treatment among people receiving opioid agonist therapy (OAT) in Norway: a prospective cohort study from 2013 to 2017
por: Aas, Christer Frode, et al.
Publicado: (2020)

Attention-deficit/hyperactivity disorder (ADHD) symptoms and their relation to diagnosed ADHD, sociodemographic characteristics, and substance use among patients receiving opioid agonist therapy: a Norwegian cohort study
por: Vold, Jørn Henrik, et al.
Publicado: (2023)

Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016–2020
por: Vold, Jørn Henrik, et al.
Publicado: (2020)

Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway
por: Aas, Christer Frode, et al.
Publicado: (2020)

Prevalence and correlates of suicide attempts in high-risk populations: a cross-sectional study among patients receiving opioid agonist therapy in Norway
por: Vold, Jørn Henrik, et al.
Publicado: (2022)

Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway
por: Aas, Christer Frode, et al.
Publicado: (2021)

Subjective symptoms and serum methadone concentrations: what should guide dose adjustments in methadone maintenance treatment? A naturalistic cohort study from Norway
por: Chalabianloo, Fatemeh, et al.
Publicado: (2021)

Changes in substance use during outpatient treatment for substance use disorders: a prospective Norwegian cohort study from 2016 to 2020
por: Vold, Jørn Henrik, et al.
Publicado: (2021)

Validation of a three-item Fatigue Severity Scale for patients with substance use disorder: a cohort study from Norway for the period 2016–2020
por: Vold, Jørn Henrik, et al.
Publicado: (2021)

Folate Status as a Nutritional Indicator among People with Substance Use Disorder; A Prospective Cohort Study in Norway
por: Bemanian, Mitra, et al.
Publicado: (2022)

Vitamin D status and associations with substance use patterns among people with severe substance use disorders in Western Norway
por: Bemanian, Mitra, et al.
Publicado: (2022)

Integrated care of severe infectious diseases to people with substance use disorders; a systematic review
por: Vold, Jørn Henrik, et al.
Publicado: (2019)

The efficacy of integrated hepatitis C virus treatment in relieving fatigue in people who inject drugs: a randomized controlled trial
por: Vold, Jørn Henrik, et al.
Publicado: (2023)

Vitamin B12 Levels, Substance Use Patterns and Clinical Characteristics among People with Severe Substance Use Disorders: A Cohort Study from Western Norway
por: Madebo, Tesfaye, et al.
Publicado: (2022)

Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV)
por: Fadnes, Lars T., et al.
Publicado: (2019)

Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV)
por: Fadnes, Lars T., et al.
Publicado: (2021)

Gender differences in physical morbidity in opioid agonist treatment patients: population-based cohort studies from the Czech Republic and Norway
por: Rolová, Gabriela, et al.
Publicado: (2023)

Association Between Prescribed Hypnotics in Infants and Toddlers and Later ADHD: A Large Cohort Study from Norway
por: Holdø, Ingvild, et al.
Publicado: (2020)

Prenatal opioid exposure and risk of asthma in childhood: a population-based study from Denmark, Norway, and Sweden
por: Odsbu, Ingvild, et al.
Publicado: (2023)

Emotional Eating and Changes in High-Sugar Food and Drink Consumption Linked to Psychological Distress and Worries: A Cohort Study from Norway
por: Javadi Arjmand, Elaheh, et al.
Publicado: (2023)

Integration of smoking cessation into standard treatment for patients receiving opioid agonist therapy who are smoking tobacco: protocol for a randomised controlled trial (ATLAS4LAR)
por: Druckrey-Fiskaaen, Karl Trygve, et al.
Publicado: (2022)

Serum concentrations of kynurenines in adult patients with attention-deficit hyperactivity disorder (ADHD): a case–control study
por: Aarsland, Tore Ivar Malmei, et al.
Publicado: (2015)

Cohort Description: Preventing an Opioid Epidemic in Norway – Focusing on Treatment of Chronic Pain (POINT) – A National Registry-Based Study
por: Hamina, Aleksi, et al.
Publicado: (2022)

Peer involvement and cross-sector efforts in establishing integrated treatment of hepatitis C virus infection for people with substance use disorders: experiences from Norway
por: Lygren, Ole Jørgen, et al.
Publicado: (2019)

Causal modelling of variation in clinical practice and long-term outcomes of ADHD using Norwegian registry data: the ADHD controversy project
por: Mykletun, Arnstein, et al.
Publicado: (2021)

Pre-injury dispensing of psychoactive prescription drugs in a ten years trauma population: a retrospective registry analysis
por: Torp, Henrik Andreas, et al.
Publicado: (2021)

Geographical variation in ADHD: do diagnoses reflect symptom levels?
por: Widding-Havneraas, Tarjei, et al.
Publicado: (2022)

Changes in Body Mass Index and Their Associations with Psychological Distress, Worries, and Emotional Eating during the COVID-19 Pandemic: A Norwegian Cohort Study
por: Arjmand, Elaheh Javadi, et al.
Publicado: (2023)

Perceived consequences and worries among youth in Norway during the COVID-19 pandemic lockdown
por: Lehmann, Stine, et al.
Publicado: (2021)

Study protocol for a multicenter investigation of reablement in Norway
por: Langland, Eva, et al.
Publicado: (2015)

Variation in attitudes toward diagnosis and medication of ADHD: a survey among clinicians in the Norwegian child and adolescent mental health services
por: Lyhmann, Ingvild, et al.
Publicado: (2022)

ADHD-hyperactive/impulsive subtype in adults
por: Gibbins, Christopher, et al.
Publicado: (2010)

Altered tryptophan and alanine transport in fibroblasts from boys with attention-deficit/hyperactivity disorder (ADHD): an in vitro study
por: Johansson, Jessica, et al.
Publicado: (2011)

Autoantibodies targeting neurotransmitter biosynthetic enzymes in attention-deficit/hyperactivity disorder (ADHD)
por: Hegvik, Tor-Arne, et al.
Publicado: (2013)

Erratum to: Study protocol for a multicenter investigation of reablement in Norway
por: Langeland, Eva, et al.
Publicado: (2015)

Sex differences in parent–offspring recurrence of attention‐deficit/hyperactivity disorder
por: Solberg, Berit S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kmk7rccjs6259ogdor76bfpr6d